Dr. Sacks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19 E 98th St
Box 1042
New York, NY 10029Phone+1 212-241-7856Fax+1 212-860-4607
Education & Training
- University of ConnecticutFellowship, Infectious Disease, 1977 - 1979
- University of ConnecticutResidency, Internal Medicine, 1975 - 1977
- Albany Medical CollegeClass of 1975
Certifications & Licensure
- NY State Medical License 1979 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex
- A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
- A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C Start of enrollment: 2005 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- In adults, risk for infective endocarditis varied for invasive dental procedures and by antibiotic prophylaxis.Henry S Sacks
Annals of Internal Medicine. 2022-12-01 - In nonhospitalized, unvaccinated adults with COVID-19, molnupiravir reduced hospitalization or death at 29 d.Henry S Sacks
Annals of Internal Medicine. 2022-04-01 - 4 citationsAutoimmune conditions in the World Trade Center general responder cohort: A nested case-control and standardized incidence ratio analysis.Henry S. Sacks, Margaret Smirnoff, Deborah Carson, Michael L. Cooney, Moshe Shapiro
American Journal of Industrial Medicine. 2021-11-25
Press Mentions
- Why Do September 11 First Responders Have a High Cancer Rate?July 28th, 2020
- Sept. 11 Responders May Be at Heightened Risk of Developing LeukemiaJanuary 14th, 2020
Grant Support
- Meta-Analysis Of CAM Therapies For HIVNational Center For Complementary &Alternative Medicine2010–2012
- Effects Of A Dietary Supplement On Non-Small Cell Lung Cancer PatientsNational Center For Research Resources2009
- Women'S Interagency HIV Study(Wihs)National Center For Research Resources2007
- A Pilot Study Of Silymarin In Patients With HIV And HCVNational Center For Research Resources2005–2007
- Women'S Interagency HIV Study(Wihs) (National Center For Research Resources2006
- WIHS Cardiovascular ComponentNational Center For Research Resources2006
- Prolong The Survival Of Nscl Patients By A PhytomixNational Center For Complementary &Alternative Medicine2004–2006
- Women'S Interagency HIV Study (WIHS)National Center For Research Resources2005
- Pilot Trial Of Silymarin In Patients With HCV And HIVNational Institute Of Nursing Research2004–2005
- Leadership Award In Complementary And Alternative MedicNational Center For Complementary &Alternative Medicine2001–2005
- Collaborative HIV/AIDS Development Project IndiaNational Center For Complementary &Alternative Medicine2003–2004
- Protease Inhibitor/Methadone Metabolism In HIV InfectionNational Center For Research Resources2000–2002
- PI &Nnrti In HIV InfectionNational Center For Research Resources2000–2002
- Phase III Trial Of Efavirenz Or Nelfinavir Lamivudine &ZidovudineNational Center For Research Resources2000–2002
- ACTG 323--Fluconazole As Chronic Supp. Therapy Vs. Episodic Therapy In HIV+ PTSNational Center For Research Resources2000–2002
- ACTG 309 Pharmacokinetics Of Antituberculosis Agents In HIV InfectedNational Center For Research Resources2000–2002
- ACTG 398 Phase II Trial Of Amprenavir Abacavir, Efavirenz &AdefovirNational Center For Research Resources1999–2002
- ACTG 372 Phase II Study Of Prolongation Of Virologic Rollover For ACTNational Center For Research Resources1999–2002
- ACTG 362 Trial To Determine Efficacy Of Azithromycin ProphylaxisNational Center For Research Resources1999–2002
- ACTG 328--Study Of Intermt. Rhil-2 Compared To HaartNational Center For Research Resources1999–2002
- ACTG 301 Trial Of Memantine For AIDS Dementia Complex (ADC)National Center For Research Resources1999–2002
- ACTG 291--Trial Of RU Human Nerve GF In HIV Assoc. Perph. NeuropathyNational Center For Research Resources1999–2002
- ACTG 364--Comparison Of The Virologic Efficacy Of Nelfinavir AND/OR DMP 266National Center For Research Resources1998–2002
- Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–2001
- Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–2001
- Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2001
- Phase III Trial Of Efavirenz Or Nelfinavir , Lamivudine / ZidovudineNational Center For Research Resources1999
- Pharmacokinetics Of Antituberculosis Agents In HIV Infected PersonsNational Center For Research Resources1999
- Fluconazole As Supp. Therapy Vs. Episodic Therapy In HIV+ PTSNational Center For Research Resources1999
- Women'S Interagency HIV Study (WIHS)National Center For Research Resources1998–1999
- ACTG 368--Phase II Trial Of 1592U89 In Combination With Indinavir SulfateNational Center For Research Resources1998–1999
- Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1997–1999
- ACTG 320--Study Of Indinavir Sulfatae With OPEN Label Zidovudine &LamivudineNational Center For Research Resources1997–1999
- ACTG 302--Virologic Responses To New Nucleoside Regimens After Prolonged ZDVNational Center For Research Resources1997–1999
- ACTG 288--Follow UP Of Women Participating In ACTG 076National Center For Research Resources1997–1999
- ACTG 254--Micronized Atovaquone &Azithromycin VS Trimethoprim/SulfamethaxzoleNational Center For Research Resources1997–1999
- ACTG 245--Combination Antiretroviral Therapy In Children &Adolescents With HIVNational Center For Research Resources1997–1999
- ACTG 219--Multicenter Trial Of The AIDS Clinical Trials GroupNational Center For Research Resources1997–1999
- ACTG 200--A Preenrollment Protocol For HIV Infected AdolescentsNational Center For Research Resources1997–1999
- ACTG 185--Phase Iii--Hivig For Prevention Of Maternal/Fetal HIV TransmissionNational Center For Research Resources1997–1999
- Randomized Comparative Study Of Combined ZDV 3TC VS DDI Monotherapy VS Zdv/DdiNational Center For Research Resources1996–1999
- ACTG 328--Phase II Study Of Intermittent Recombinant Human Interleukin 2National Center For Research Resources1998
- ACTG 323--Phase IV Randomized Study Of The Use Of FluconazoleNational Center For Research Resources1998
- ACTG 291--Phase II Trial Of Recombinant Human Nerve Growth FactorNational Center For Research Resources1997–1998
- ACTG 261--Phase II Double Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1997
- ACTG 251--Thalidomide For Treatment Of Oral And Esophageal UlcersNational Center For Research Resources1997
- ACTG 250--Phase I Study--Nevirapine In HIV I Infected Pregnant Women And NeonatesNational Center For Research Resources1997
- ACTG 243--Phase II Study Comparing Antiretroviral Therapy Alone Or With ARA-CNational Center For Research Resources1997
- ACTG 242--Phase II/III Double Blind Study Of Amitriptyline And MexiletineNational Center For Research Resources1997
- ACTG 240--Randomized Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1997
- ACTG 222--Treatment Of Mycobacterium Tuberculosis In HIV InfectionNational Center For Research Resources1997
- ACTG 215--Phase I Study Of Tnp470 In Treatment Of AIDS Associated Kaposis SarcomaNational Center For Research Resources1997
- ACTG 206--Randomized Phase II Trial Of Interferon With Didanosine In Kaposis SarcNational Center For Research Resources1997
- ACTG 175--Monotherapy VS Combination Therapy With Nucleoside Analogues In HIVNational Center For Research Resources1997
- ACTG 076--Safety &Tolerance Of ZDV For Prevention Of Maternal/Fetal HIV InfectioNational Center For Research Resources1997
- Womens Interagency HIV StudyNational Center For Research Resources1996–1997
- Four-Arm Study Comparing Combination To Monthly Alternating Nucleoside TherapyNational Center For Research Resources1996–1997
- Early Diagnosis Of Pediatric HIV InfectionNational Center For Research Resources1993–1997
- Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1996
- Two Arm Study Micronized Atovaquone Azithromycin VS Trimethoprim/SulfamethaxzoleNational Center For Research Resources1996
- Randomized Double Blind Trial Of Bw256u87 ProphylaxisNational Center For Research Resources1996
- Randomized Comparative Study Of Daily Dapsone And Daily Atovaquone Against PCPNational Center For Research Resources1996
- Phase III Randomized--Hivig For Prevention Of Maternal Fetal HIV TransmissionNational Center For Research Resources1996
- Phase III Randomized Trial Of Low Dose M Bacod Chemotherapy VS Standard DoseNational Center For Research Resources1996
- Phase II/III Double Blind Study Of Amitriptyline And Mexiletine--Hiv InfectionNational Center For Research Resources1996
- Phase II Multicenter Study Comparing Antiretroviral Therapy Alone To ARACNational Center For Research Resources1996
- Phase II Double Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1996
- Phase I Study--Nevirapine In HIV I Infected Pregnant Women And NeonatesNational Center For Research Resources1996
- Phase I Study Of Tnp470 In The Treatment Of AIDS Associated Kaposis SarcomaNational Center For Research Resources1996
- Follow UP Of Women Participating In ACTG 076National Center For Research Resources1996
- Combination Of Zidovudine, Didanosine, And Double Blinded NevirapineNational Center For Research Resources1996
- Combination Antiretroviral Therapy In Children &Adolescents With Advanced HIVNational Center For Research Resources1996
- A Randomized Phase II Trial Of Interferon With Didanosine In Kaposi'S SarcomaNational Center For Research Resources1996
- Treatment Of Mycobacterium Tuberculosis In HIV InfectionNational Center For Research Resources1995–1996
- Thalidomide For Treatment Of Ulcers And HIV ViremiaNational Center For Research Resources1995–1996
- Safety &Tolerance Of ZDV For Prevention Of Maternal-Fetal HIV InfectionNational Center For Research Resources1995–1996
- Randomized Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1995–1996
- Multicenter Trial Of The AIDS Clinical Trials GroupNational Center For Research Resources1995–1996
- Trial Of ZDV VS DDI VS Zdv+Ddi In Symptomatic HIV Infected ChildrenNational Center For Research Resources1994–1996
- Study To Evaluate Activity Of Dideoxycytidine In Combination With ZidovudineNational Center For Research Resources1994–1996
- DDC Alone Or Ddc/Zdv Combination VS Zidovudine Alone In Patients With HIVNational Center For Research Resources1994–1996
- Clarithromycin VS Rifabutin VS Combination Of Clarithromycin PLUS RifabutinNational Center For Research Resources1994–1996
- Pediatric AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1993–1996
- Monotherapy VS Combination Therapy With Nucleoside Analogues In HIV PersonsNational Center For Research Resources1993–1996
- Double Blind Comparison Of ZDV VS D4T For Patients With HIV InfectionNational Center For Research Resources1993–1996
- Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1996
- Phase II Double-Blind Study Of Sc-49483 In Combination With ZidovudineNational Center For Research Resources1995
- Phase II Double-Blind Study Of Delavirdine, Zidovudine, And DidanosineNational Center For Research Resources1995
- Combination Of Zidovudine, Didanosine, And Double-Blinded NevirapineNational Center For Research Resources1995
- A Randomized Phase 11 Trial Of Interferon With Didanosine In Kaposi'S SarcomaNational Center For Research Resources1995
- Meta Analysis Of The AIDS LiteratureNational Institute Of Mental Health1994–1995
- AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
- Tolerance Of High VS Low Dose Zidovudine Administered To Children With HIVNational Center For Research Resources1994–1995
- Three-Arm Study Comparing Combination To Monthly Alternating Nucleoside TherapyNational Center For Research Resources1994–1995
- Safety And Efficacy Of ZDV For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1994–1995
- Randomized Double-Blind Trial Of BW 256u87 ProphylaxisNational Center For Research Resources1994–1995
- Pediatric AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1993–1995
- Trial Of Nimodipine For AIDS Dementia Complex With ZidovudineNational Center For Research Resources1993–1995
- Feasibility Of Fluconazole For Relapse Of Histoplasmosis In Patients With AIDSNational Center For Research Resources1993–1995
- Safety &Tolerance Of Oral Zidovudine In Hiv-Infected Pregnant Women TNational Center For Research Resources1994
- Evaluation Of SQ 32,756 (Bv-Arau) VS Acyclovir In The Treatment Of Herpes ZosterNational Center For Research Resources1994
- Combination Of Zidovudine, Didanosine, And Doubl-Blinded NevirapineNational Center For Research Resources1994
- A Randomized Phase 11 Trial Of Interferon With Didanosine...Kaposi'S SarcomaNational Center For Research Resources1994
- Trial Of 2',3'-Dideoxyinosine In Children With Symptomatic HIVNational Center For Research Resources1993–1994
- Rifampin, Ciprofloxacin,...Mycobacterium Avium Infection In HIV InfectionNational Center For Research Resources1993–1994
- Prophylaxis Against MTB In Patients Infected With HIVNational Center For Research Resources1993–1994
- Combination Chemotherapy And DDI Or DDC In The Treatment Of Kaposi'S SarcomaNational Center For Research Resources1993–1994
- Phase II Study Comparing 2'3'-Ddi And Zidovudine Therapy In PTS With AIDS Or ARCNational Center For Research Resources1992–1994
- Dapsone/Trimethoprim &Clindamycin/Primaquine VS Trimethoprim/SulfamethoxazoleNational Center For Research Resources1992–1994
- Bmy-27857 (2'3'-Didehydro-3'-Deoxythymidine, D4t) Administered To HIV+ PatientsNational Center For Research Resources1992–1994
- Early Diagnosis Of Pediatric HIV InfectionNational Institute Of Allergy And Infectious Diseases1991–1994
- Gamma Globulin And AZT In Children With HIV InfectionNational Center For Research Resources1990–1994
- Short-Term Research TrainingNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1994
- Trial Of Zvd VS DDI VS Zvd+Ddi In Symptomatic HIV Infected ChildrenNational Center For Research Resources1993
- Safety And Tolerance Of Oral Zidovudine In Pregnancy HIV Infected WomenNational Center For Research Resources1993
- Pyrimethamine Pharmacokinetics In HIV+ Patients Seropotive For T. GondiNational Center For Research Resources1993
- 2'3'-Dideoxyinosine And Zidovudine In The Therapy Of Patients With AIDS Or ARCNational Center For Research Resources1993
- Two Doses Of 2', Or 3'-Ddc In Treatment Of Children Intolerant To ZDVNational Center For Research Resources1992–1993
- Randomized Study Of DDC Alone Or Ddc/Zdv Combination VS Zidovudine AloneNational Center For Research Resources1992–1993
- Primary Prophylaxis Of Cerebral Toxoplasmosis In Hiv-Infected PatientsNational Center For Research Resources1992–1993
- Phase I Safety And Pharmacokinetics Study Of D4T In Patients With AIDS Or ARCNational Center For Research Resources1992–1993
- High VS Low Dose Zidovudine Administered To Children With HIVNational Center For Research Resources1992–1993
- Meta-Analysis Of The AIDS LiteratureNational Institute Of Mental Health1991–1993
- Safety And Efficacy Of Zvd For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1991–1993
- Potential Of Low Dose Therapy With ZDV And Interferon Alpha 2ANational Center For Research Resources1991–1993
- Efficacy Of 2'3'Ddi Given Orally 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1991–1993
- Anti-Pneumocystis Agents PLUS ZDV For Prevention Of Serious InfectionsNational Center For Research Resources1991–1993
- Establishment Of AIDS Treatment Evaluation UnitNational Institute Of Allergy And Infectious Diseases1992
- Pyrimethamine Pharmacokinetics In HIV+ Patients Seropotivie For T GondiNational Center For Research Resources1992
- Comparison Of 2',3'-Ddi Given Orally 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1992
- AZT In Treatment Of HIV Infection In Hemophilic PatientsNational Center For Research Resources1992
- Safety/Efficicy Of ZDV In Therapy Of Patients With Early ARCNational Center For Research Resources1991–1992
- Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–1992
- Phase II Study Comparing 2'3'-Ddi And Zivoduine Therapy In PTS With AIDS Or ARCNational Center For Research Resources1991
- Foscarnet Salvage Therapy For AIDS Patients With Sight Threatening CMV RetinitisNational Center For Research Resources1991
- Comparison Of 2',3'-Ddi Given Oraly 2/Day To Patients With AIDS Or ARCNational Center For Research Resources1991
- Fluconqzole And Amphotaercin B In AIDS Patients With Crytococcal MeningitisNational Center For Research Resources1990–1991
- Placebo Controlled Trial To Evaluate ZDV In Treatment Of HIV In Hemophilic PTSNational Center For Research Resources1989–1991
- PCP In Aids--Trimetrexae With Leacovorin CA Rescue VS Trimethoprim/SulfamethoxNational Center For Research Resources1989–1991
- The Establishment Of AIDS Treatment Evaluation UnitNational Institute Of Allergy And Infectious Diseases1988–1991
- Phase I Safety &Pharmacokinetics Of D4T In Patients With AIDS Or ARCNational Center For Research Resources1990
- Phase ONE Study Of As-101 In Patients With AIDS And ARCNational Center For Research Resources1989–1990
- PCP In Aids--Aerosolized Pentamidine VS Parental/Oral Trimethrapin-SulfamethoxNational Center For Research Resources1989
- Fluconqzole And Amphotaercin B In AIDS PTS. With Crytococcal MeningitisNational Center For Research Resources1989
- Ateu 2:Azt In Treatment Of HIV Infection With AIDS Post First EpisodeNational Center For Research Resources1988
- Aeu1:Azt In Treatment Of HIV Infection With Aids-Associated Kaposi'S SarcomaNational Center For Research Resources1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: